コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
2 f-function (rf) mutants of daf-2, an insulin/insulinlike growth factor (IGF) receptor (INR) homolog g
3 factor (HGF), epidermal growth factor (EGF), insulinlike growth factor (IGF)-1, tumor necrosis factor
4 The authors examined the interaction between insulinlike growth factor (IGF)-1, vascular endothelial
7 Neither exogenous interleukin-6 (IL-6) nor insulinlike growth factor 1 (IGF-1) overcomes Perifosine
8 ebo titrated to the upper quartile of normal insulinlike growth factor 1 (IGF-1) range for 18 months.
9 tiation and fiber type specificity due to an insulinlike growth factor 1 (IGF-1)-calcineurin-NFAT sig
10 e in granulocyte IGF-IR expression and serum insulinlike growth factor 1 accumulation at high doses,
12 tio, 5.33 [95% CI, 0.97-29.30]; P = .06) and insulinlike growth factor 1 receptor (hazard ratio, 2.74
13 T to monitor therapy with an antibody to the insulinlike growth factor 1 receptor (IGF-1R antibody) i
14 , and pharmacodynamic properties of the anti-insulinlike growth factor 1 receptor (IGF-IR) monoclonal
16 glucose), growth factors (e.g., insulin and insulinlike growth factor 1), hormones (e.g., leptin), a
17 ified calgranulin B and a unique fragment of insulinlike growth factor binding protein 1, which were
18 a linear survival signaling cascade used by insulinlike growth factor I (IGF-I) that consists of the
20 ropoietin, transforming growth factor beta1, insulinlike growth factor type 1, angiopoietin 1, angiop
21 ctor [VEGF], hepatocyte growth factor [HGF], insulinlike growth factor-1 [IGF-1], and thrombopoietin
22 IMiDs also block the stimulatory effect of insulinlike growth factor-1 on NF-kappa B activity and p
23 ancer growth regulation, we exposed cells to insulinlike growth factor-1 or transferrin, which increa
26 talloproteinase 1 and 2 (TIMP-1 and TIMP-2), insulinlike growth factor-binding protein 2 (IGFBP-2), n
27 nificantly attenuated the release of urinary insulinlike growth factor-binding protein 7 and tissue i
29 6), tumor necrosis factor-alpha (TNF-alpha), insulinlike growth factor-I (IGF-I), and IGF binding pro
31 pathway, closely related to the insulin and insulinlike growth factor-signaling pathways of mammals,
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。